The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.
The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.
Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.
The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.
Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.
For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.
This product will be delivered within 1-3 business days.
The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.
Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.
The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.
Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.
For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.
North America In Vitro Diagnostics Market Report Highlights
- The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
- The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
- Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
- The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
- Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology And Scope1.1 Market Segmentation And Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 North America Ivd Market Variables, Trends, & Scope
3.1 Ivd Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration And Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Growing Geriatric Population
3.3.2 Technological Advancements
3.3.3 Increasing Demand For Poc Facilities
3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
3.3.5 Outbreak Of Covid-19
3.4 Market Restraint Analysis
3.4.1 High Cost Of Devices
3.4.2 Stringent Regulatory Policies
3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.6 Porter’s Five Forces Analysis
3.7 Pipeline Analysis, By Phase
3.8 Regulatory & Reimbursement Scenario
3.9 Pricing Analysis
Chapter 4 North America Ivd Market-Segment Analysis, By Product, 2018 - 2030 (Volume, Number Of Tests And Instruments; Revenue, USD Million, 2018 - 2030)
4.1 North America In Vitro Diagnostic Market: Products Movement Analysis
4.2 Instruments
4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 Hospitals
4.2.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.3 Laboratories
4.2.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.4 Home Care
4.2.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5 Clinic
4.2.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5.2 Physician Office
4.2.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5.3 Pharmacy & Retail Clinics
4.2.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5.4 Non-Practice Clinics
4.2.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5.5 Urgent Care Clinics
4.2.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5.6 Others
4.2.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Reagents
4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.2 Hospitals
4.3.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.3 Laboratories
4.3.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.4 Home Care
4.3.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5 Clinic
4.3.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5.2 Physician Office
4.3.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5.3 Pharmacy & Retail Clinics
4.3.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5.4 Non-Practice Clinics
4.3.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5.5 Urgent Care Clinics
4.3.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5.6 Others
4.3.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Services
4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.2 Hospitals
4.4.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.3 Laboratories
4.4.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.4 Home Care
4.4.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5 Clinic
4.4.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5.2 Physician Office
4.4.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5.3 Pharmacy & Retail Clinics
4.4.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5.4 Non-Practice Clinics
4.4.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5.5 Urgent Care Clinics
4.4.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5.6 Others
4.4.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 North America Ivd Market-Segment Analysis, By Technology, 2018 - 2030 (Revenue, USD Million) (Volume, Number Of Test And Instruments)
5.1 North America In Vitro Diagnostics Market: Technology Movement Analysis
5.2 Immunoassay
5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2 Products
5.2.2.1 Instruments
5.2.2.1.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2.2 Reagents
5.2.2.2.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2.3 Services
5.2.2.3.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3 End-Use
5.2.3.1 Hospitals
5.2.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.2 Laboratories
5.2.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.3 Home Care
5.2.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.4 Clinic
5.2.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.4.2 Physician Office
5.2.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.4.3 Pharmacy & Retail Clinics
5.2.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.4.4 Non-Practice Clinics
5.2.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.4.5 Urgent Care Clinics
5.2.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3.4.6 Others
5.2.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Hematology
5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.2 Products
5.3.2.1 Instruments
5.3.2.1.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.2.2 Reagents
5.3.2.2.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.2.3 Services
5.3.2.3.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3 End-Use
5.3.3.1 Hospitals
5.3.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.2 Laboratories
5.3.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.3 Home Care
5.3.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.4 Clinic
5.3.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.4.2 Physician Office
5.3.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.4.3 Pharmacy & Retail Clinics
5.3.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.4.4 Non-Practice Clinics
5.3.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.4.5 Urgent Care Clinics
5.3.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3.4.6 Others
5.3.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Clinical Chemistry
5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.2 Products
5.4.2.1 Instruments
5.4.2.1.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.2.2 Reagents
5.4.2.2.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.2.3 Services
5.4.2.3.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3 End-Use
5.4.3.1 Hospitals
5.4.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.2 Laboratories
5.4.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.3 Home Care
5.4.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.4 Clinic
5.4.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.4.2 Physician Office
5.4.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.4.3 Pharmacy & Retail Clinics
5.4.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.4.4 Non-Practice Clinics
5.4.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.4.5 Urgent Care Clinics
5.4.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3.4.6 Others
5.4.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Molecular Diagnostics
5.5.1 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.2 Products
5.5.2.1 Instruments
5.5.2.1.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.2.2 Reagents
5.5.2.2.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.2.3 Services
5.5.2.3.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3 End-Use
5.5.3.1 Hospitals
5.5.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.2 Laboratories
5.5.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.3 Home Care
5.5.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.4 Clinic
5.5.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.4.2 Physician Office
5.5.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.4.3 Pharmacy & Retail Clinics
5.5.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.4.4 Non-Practice Clinics
5.5.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.4.5 Urgent Care Clinics
5.5.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3.4.6 Others
5.5.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Coagulation
5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.2 Products
5.6.2.1 Instruments
5.6.2.1.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.2.2 Reagents
5.6.2.2.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.2.3 Services
5.6.2.3.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3 End-Use
5.6.3.1 Hospitals
5.6.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.2 Laboratories
5.6.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.3 Home Care
5.6.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.4 Clinic
5.6.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.4.2 Physician Office
5.6.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.4.3 Pharmacy & Retail Clinics
5.6.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.4.4 Non-Practice Clinics
5.6.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.4.5 Urgent Care Clinics
5.6.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3.4.6 Others
5.6.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Microbiology
5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.2 Products
5.7.2.1 Instruments
5.7.2.1.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.2.2 Reagents
5.7.2.2.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.2.3 Services
5.7.2.3.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3 End-Use
5.7.3.1 Hospitals
5.7.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.2 Laboratories
5.7.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.3 Home Care
5.7.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.4 Clinic
5.7.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.4.2 Physician Office
5.7.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.4.3 Pharmacy & Retail Clinics
5.7.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.4.4 Non-Practice Clinics
5.7.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.4.5 Urgent Care Clinics
5.7.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3.4.6 Others
5.7.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8 Others
5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8.2 Instruments
5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8.3 Reagents
5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8.4 Services
5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 North America Ivd Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1 North America In Vitro Diagnostics Market: Application Movement Analysis
6.2 Infectious Diseases
6.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 Disease
6.2.2.1. Methicillin-Resistant Staphylococcus Aureus (Mrsa)
6.2.2.1.1 Methicillin-Resistant Staphylococcus Aureus (Mrsa) Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.1.2 Clostridium Difficile
6.2.2.1.2.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.1.3 Vancomycin-Resistant Enterococci (Vre)
6.2.2.1.3.1 Vancomycin-Resistant Enterococci (Vre) Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.1.4 Carbapenem-Resistant Bacteria
6.2.2.1.4.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 5 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 6 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 7 North America In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
Table 8 North America In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 9 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
Table 10 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 11 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 12 U.S. In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
Table 13 U.S. In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 14 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
Table 15 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 16 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
Table 17 Canada In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
Table 18 Canada In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of
Table 19 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 North America in vitro diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Segment snapshot
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Penetration and growth prospect mapping
Fig. 15 North America in vitro diagnostic market driver impact
Fig. 16 Geriatric population in the U.S.
Fig. 17 Comparison of geriatric population in the U.S.
Fig. 18 Proportion of Canadian population in 2022
Fig. 19 Number of deaths for leading causes of death
Fig. 20 North America in vitro diagnostics market restraint impact
Fig. 21 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 22 Porter’s five forces analysis
Fig. 23 Taking control of the changing regulatory landscape
Fig. 24 North America IVD market: Product outlook and key takeaways
Fig. 25 North America. IVD market: Products movement analysis
Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Home care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Home care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Home care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 North America IVD market: Technology outlook and key takeaways
Fig. 57 North America IVD market: Technology movement analysis
Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 North America IVD market: Application outlook and key takeaways
Fig. 68 North America IVD market: Application movement analysis
Fig. 69 Meningitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Percentage of osteoporosis affecting men and women
Fig. 71 North America IVD market: End-use outlook and key takeaways
Fig. 72 Home care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Key stats related to retail clinics in the U.S.
Fig. 74 Regional marketplace: Key takeaways
Fig. 75 North America: SWOT analysis
Fig. 76 North America IVD market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Risk factors and major chronic diseases in the U.S.
Fig. 79 U.S. healthcare reimbursement and financing structure
Fig. 80 U.S. IVD market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Target disease prevalence in Canada
Fig. 83 Canada IVD market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Market participant categorization
Fig. 85 North America IVD market share analysis, 2022
Fig. 86 Strategic framework
Fig. 87 Competition categorization
Fig. 88 Company market position analysis
Fig. 89 Company market position analysis
Fig. 90 Company market position analysis
Fig. 91 Regional network map
Companies Mentioned
- Abbott
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- BD
- Siemens Healthcare GmbH
- QIAGEN
- Quidel Corporation
- F. Hoffmann-La Roche Ltd
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- Quest Diagnostics
- Agilent Technologies, Inc.
- Danaher
Methodology
LOADING...
